Clinical Trial: To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07230184) titled 'To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR' on Sept. 22.

Brief Summary: This study is planned to evaluate the efficacy and safety of combination therapy with B55R1 and B55R2 compared to B55R1 monotherapy in patients with non-proliferative diabetic retinopathy (NPDR).

Study Start Date: April 28, 2022

Study Type: INTERVENTIONAL

Condition: Non-Proliferative Diabetic Retinopathy

Intervention: DRUG: B55R1 and B55R2

After Randomization(Week 0), Participants will be administered with the drug, 2 times in a day, until end of trial(Week 24).

DRUG...